Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Mar-21 4:02 PM View:  | Fate Therapeutics Inc (FATE) | 08-Mar-21 | Market Sale (Planned) | 25,000 | $81.74 | $2,043,430.00 | (26%) 98.02K to 73.02K | 3% |
| 22-Jan-21 6:19 PM View: | Fate Therapeutics Inc (FATE) | 20-Jan-21 | Grant | 14,411 | -- | -- | 17% 83.61K to 98.02K | |
| 12-Jan-21 8:38 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-21 | Market Sale | 3,253 | $110.81 | $360,477.00 | (4%) 86.86K to 83.61K | (1%) |
| 12-Jan-21 8:38 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-21 | Market Sale | 6,229 | $117.10 | $729,434.00 | (7%) 93.09K to 86.86K | 4% |
| 16-Nov-20 5:12 PM View: | Fate Therapeutics Inc (FATE) | 16-Nov-20 | Market Sale (Planned) | 25,000 | $51.83 | $1,295,750.00 | (21%) 118.09K to 93.09K | (94%) |
| 16-Sep-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 14-Sep-20 | Market Sale (Planned) | 25,000 | $36.30 | $907,540.00 | (17%) 143.09K to 118.09K | (178%) |
| 10-Jan-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-20 | Grant | 25,000 | -- | -- | 20% 123.79K to 148.79K | |
| 10-Jan-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-20 | Market Sale | 5,700 | $20.70 | $117,986.00 | (4%) 148.79K to 143.09K | (387%) |
| 02-Jan-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 30-Dec-19 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 20% 123.79K to 148.79K | |
| 02-Jan-20 4:01 PM View: | Fate Therapeutics Inc (FATE) | 30-Dec-19 | Market Option Sale (Planned) | 25,000 | $19.50 | $487,427.00 | (17%) 148.79K to 123.79K | (417%) |
| 16-Oct-19 4:04 PM View: | Fate Therapeutics Inc (FATE) | 15-Oct-19 | Market Sale | 11,800 | $14.29 | $168,592.00 | (9%) 135.59K to 123.79K | (605%) |
| 28-Jun-19 4:02 PM View: | Fate Therapeutics Inc (FATE) | 27-Jun-19 | Option Exercise | 12,500 | $2.90 | $36,250.00 | 9% 135.59K to 148.09K | |
| 28-Jun-19 4:02 PM View: | Fate Therapeutics Inc (FATE) | 27-Jun-19 | Market Option Sale (Planned) | 12,500 | $20.21 | $252,610.00 | (8%) 148.09K to 135.59K | (398%) |
| 29-Mar-19 4:01 PM View: | Fate Therapeutics Inc (FATE) | 28-Mar-19 | Option Exercise | 12,500 | $2.90 | $36,250.00 | 9% 135.59K to 148.09K | |
| 29-Mar-19 4:01 PM View: | Fate Therapeutics Inc (FATE) | 28-Mar-19 | Market Option Sale (Planned) | 12,500 | $16.94 | $211,702.00 | (8%) 148.09K to 135.59K | (495%) |
| 09-Jan-19 4:01 PM View: | Fate Therapeutics Inc (FATE) | 07-Jan-19 | Grant | 45,000 | -- | -- | 50% 90.59K to 135.59K | |
| 17-Oct-17 4:04 PM View: | Fate Therapeutics Inc (FATE) | 16-Oct-17 | Market Sale | 700 | $4.08 | $2,856.00 | (< 1%) 91.29K to 90.59K | (2367%) |
| 17-Oct-17 4:04 PM View: | Fate Therapeutics Inc (FATE) | 13-Oct-17 | Market Sale | 12,525 | $3.86 | $48,346.50 | (12%) 103.82K to 91.29K | (2508%) |
| 12-Jan-16 5:32 PM View: | Fate Therapeutics Inc (FATE) | 08-Jan-16 | Grant | 9,388 | -- | -- | 10% 94.43K to 103.82K | |
| 16-Oct-15 5:35 PM View: | Fate Therapeutics Inc (FATE) | 15-Oct-15 | Grant | 66,000 | -- | -- | 232% 28.43K to 94.43K | |
| 07-Jan-15 5:35 PM View: | Fate Therapeutics Inc (FATE) | 05-Jan-15 | Grant | 2,466 | -- | -- | 9% 25.96K to 28.43K | |
| 02-Apr-14 12:07 PM View: | Fate Therapeutics Inc (FATE) | 31-Mar-14 | Market Sale (Planned) | 8,653 | $9.86 | $85,361.00 | (25%) 34.62K to 25.96K | (900%) |